You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glial Cell Tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

hPG80 asBlood Biomarker for High-grade Glial Tumors

Recruiting
  • Glial Cell Tumors
  • Blood sample
  • Clermont-Ferrand, France
    Centre Jean PERRIN
Feb 14, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Glial Cell Tumors, Malignant Gliomas, Glioblastoma Multiforme Trial in United States (Valproic acid, Bevacizumab, Radiation

Completed
Has Results
  • Glial Cell Tumors
  • +7 more
  • Valproic acid
  • +2 more
  • Oklahoma City, Oklahoma
  • +5 more
Jun 30, 2021

Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

Not yet recruiting
  • Advanced Solid Tumors
  • B-cell Non-Hodgkin Lymphomas
  • (no location specified)
Aug 31, 2023

Solid Tumors Trial (IBR854 Cell Injection)

Not yet recruiting
  • Solid Tumors
  • IBR854 Cell Injection
  • (no location specified)
Aug 14, 2023

Germ Cell Tumors of the Central Nervous System

Recruiting
  • Germ Cell Tumor of CNS
    • Beijing, China
      Sanbo Brain Hospital Capital Medical University
    Apr 19, 2023

    NSCLC, Solid Tumors, Programmed Cell Death-1 (PD1, PD-1) Trial (MK-2870, Pembrolizumab, Carboplatin)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +4 more
    • MK-2870
    • +2 more
    • (no location specified)
    Sep 15, 2023

    Germ Cell Tumor Trial (Thromboprophylaxis)

    Not yet recruiting
    • Germ Cell Tumor
    • (no location specified)
    May 16, 2023

    Head and Neck Squamous Cell Carcinoma Trial (HS-20093)

    Not yet recruiting
    • Head and Neck Squamous Cell Carcinoma
    • (no location specified)
    Aug 17, 2023

    Malignant Ovarian Germ Cell Tumors

    Recruiting
    • Fertility Issues
    • observational study
    • Cairo, Egypt
      Department of Obstetrics & Gynecology
    Jun 7, 2023

    Mesothelin-positive Advanced Malignant Solid Tumors Trial in Hangzhou (UCLM802 Cell Injection (Anti-mesothelin CAR-T cells))

    Recruiting
    • Mesothelin-positive Advanced Malignant Solid Tumors
    • UCLM802 Cell Injection (Anti-mesothelin CAR-T cells)
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital Zhejiang University School of Medi
    May 11, 2023

    19 and 22+ B Cell Hematologic Tumors Trial in Wuhan (Autologous CD19/CD22 Chimeric Antigen Receptor T-cells)

    Recruiting
    • 19 and 22+ B Cell Hematologic Tumors
    • 19 and 20+ B Cell Hematologic Tumors
    • Autologous CD19/CD22/CD20 Chimeric Antigen Receptor T-cells
    • Wuhan, Hubei, China
      Tongji Hospital
    Jan 11, 2023

    Carcinoma, Squamous Cell of Head and Neck, NSCLC, Ovarian Tumors Trial (disitamab vedotin)

    Not yet recruiting
    • Carcinoma, Squamous Cell of Head and Neck
    • +3 more
    • disitamab vedotin
    • (no location specified)
    Aug 15, 2023

    Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced

    Completed
    • Parkinson's Disease
    • Convection enhanced delivery/AAV2-GDNF
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    PARP Inhibitor for Esophageal Squamous Cell Carcinoma Trial (Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only

    Not yet recruiting
    • PARP Inhibitor for Esophageal Squamous Cell Carcinoma
    • Fluzoparib monotherapy or Fluzoparib with Camrelizumab(Only non-small cell lung cancer arm) ,or Fluzoparib combined with capecitabine (only rectal cancer arm))
    • (no location specified)
    Sep 24, 2023

    Perivascular Epithelioid Cell Tumors

    Recruiting
    • Perivascular Epithelioid Cell Tumor, Malignant
      • Strasbourg, France
        Service d'Oncologie - CHU de Strasbourg - France
      Nov 7, 2022

      Multiple Myeloma Trial in Wuhan (SENL103)

      Recruiting
      • Multiple Myeloma
      • SENL103
      • Wuhan, Hubei, China
        Tongji Hospital
      Sep 27, 2023

      Drug Resistant Epilepsy Trial in Medan (Cholecalciferol, )

      Not yet recruiting
      • Drug Resistant Epilepsy
      • Medan, North Sumatra, Indonesia
        Faculty of Medicine Universitas Sumatera Utara
      Sep 21, 2023

      Solid Tumor Trial (UCLM802 Cell Injection)

      Not yet recruiting
      • Solid Tumor
      • UCLM802 Cell Injection
      • (no location specified)
      Mar 7, 2023

      CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

      Active, not recruiting
      • Central Nervous System Tumor, Pediatric
      • +8 more
      • EGFR806-specific chimeric antigen receptor (CAR) T cell
      • Seattle, Washington
        Seattle Children's Hospital
      Jan 18, 2023

      Multi-dimensional Fragmentomic Assay for Early Detection of

      Not yet recruiting
      • Pancreatic Neuroendocrine Tumor
      • Fragmentomic profiles of plasma cfDNA
      • (no location specified)
      Apr 27, 2023

      Gastrointestinal Tumors Trial in Zhengzhou (First dose, Second dose, The third dose)

      Recruiting
      • Gastrointestinal Tumors
      • First dose
      • +3 more
      • Zhengzhou, Henan, China
        The First Affiliated Hospital of Zhengzhou University
      Nov 22, 2023

      MiRNA in Detecting Active Germ Cell Tumors in Early Suspected

      Recruiting
      • Malignant Testicular Germ Cell Tumor
      • Non-Interventional Study
      • Los Angeles, California
      • +1 more
      Sep 28, 2023

      NSCLC Trial in Shanghai (BL-M02D1)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Jul 10, 2023

      NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +5 more
      • Autologous, engineered T Cells targeting TP53 R175H
      • Duarte, California
        City of Hope
      May 17, 2023